TELVYDA Trademark

Trademark Overview

On Friday, March 10, 2017, a trademark application was filed for TELVYDA with the United States Patent and Trademark Office. The USPTO has given the TELVYDA trademark a serial number of 87367216. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 17, 2021. This trademark is owned by Glaxo Group Limited. The TELVYDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
telvyda

General Information

Serial Number87367216
Word MarkTELVYDA
Filing DateFriday, March 10, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 17, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, May 17, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 17, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2020EXTENSION 5 GRANTED
Tuesday, September 8, 2020EXTENSION 5 FILED
Thursday, September 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 8, 2020TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 7, 2020EXTENSION 4 GRANTED
Friday, February 7, 2020EXTENSION 4 FILED
Friday, February 7, 2020TEAS EXTENSION RECEIVED
Wednesday, October 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2019EXTENSION 3 GRANTED
Monday, September 30, 2019EXTENSION 3 FILED
Monday, September 30, 2019TEAS EXTENSION RECEIVED
Tuesday, April 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 29, 2019EXTENSION 2 GRANTED
Friday, March 29, 2019EXTENSION 2 FILED
Friday, March 29, 2019TEAS EXTENSION RECEIVED
Friday, October 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 3, 2018EXTENSION 1 GRANTED
Wednesday, October 3, 2018EXTENSION 1 FILED
Wednesday, October 3, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 3, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 8, 2017NON-FINAL ACTION E-MAILED
Thursday, June 8, 2017NON-FINAL ACTION WRITTEN
Monday, June 5, 2017ASSIGNED TO EXAMINER
Thursday, March 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 14, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

telvyda pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological